title: Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.
abstract: Abnormal cholesterol metabolism is an established feature of Alzheimer's disease (AD). Cerebrospinal fluid (CSF) is the fluid surrounding the central nervous system, and the protein and lipid content alterations in the CSF could be biomarkers for degenerative changes in the brain. The laboratory diagnosis of AD is limited to the analysis of three biomarkers in CSF: Aβ42, total tau, and phospho-tau. The purpose of this analysis is to systematically analyze the available data describing the biomarkers of cholesterol and its metabolites in the CSF of subjects with AD. MEDLINE, EMBASE, and the Cochrane Central database were systematically queried to collect studies that have evaluated the markers of cholesterol and its metabolites in the CSF of subjects with mild cognitive impairment (MCI) or AD and age-matched controls. Analysis of the published data shows that the levels of cholesterol are increased in MCI subjects; 24-hydroxycholesterol and 27-hydroxycholesterol are elevated in AD and MCI subjects compared to controls. There is a significant dysfunction of cholesterol metabolism in the CSF of AD subjects. This analysis indicates that in addition to the available biomarkers in the CSF, such as Aβ42, total tau, and phospho-tau, 24-hydroxycholesterol, 27-hydroxycholesterol, and cholesterol appear to be sensitive biomarkers for the evaluation of MCI and AD.
authors.affiliation: Department of Neurology, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
authors.forename: Hua-Long
authors.initials: HL
authors.lastname: Wang
authors.affiliation: Department of Neurology, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
authors.forename: Yan-Yong
authors.initials: YY
authors.lastname: Wang
authors.affiliation: Department of Rehabilitation, Jingxing Hospital, Jingxing, Hebei, PR China.
authors.forename: Xin-Gang
authors.initials: XG
authors.lastname: Liu
authors.affiliation: Department of Neurology, Columbia University, New York, NY, USA.
authors.forename: Sheng-Han
authors.initials: SH
authors.lastname: Kuo
authors.affiliation: Department of Neurology, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.
authors.forename: Na
authors.initials: N
authors.lastname: Liu
authors.affiliation: Department of Reproductive Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
authors.forename: Qiao-Yun
authors.initials: QY
authors.lastname: Song
authors.affiliation: Department of Neurology, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China.|Brain Aging and Cognitive Neuroscience Laboratory of Hebei province, Shijiazhuang, Hebei, PR China.
authors.forename: Ming-Wei
authors.initials: MW
authors.lastname: Wang
mesh_terms: D000544:Alzheimer Disease / Q000134:cerebrospinal fluid*; D002784:Cholesterol / Q000134:cerebrospinal fluid*; D060825:Cognitive Dysfunction / Q000134:cerebrospinal fluid*; D016206:Databases, Bibliographic / Q000706:statistics & numerical data; D006801:Humans; D006888:Hydroxycholesterols / Q000134:cerebrospinal fluid*
chemical_list: D006888:Hydroxycholesterols; C044563:24-hydroxycholesterol; C076996:27-hydroxycholesterol; D002784:Cholesterol
keywords: 24-hydroxycholesterol; 27-hydroxycholesterol; Alzheimer’s disease; cerebrospinal fluid; cholesterol
references.citation: J Psychiatr Res. 2002 Jan-Feb;36(1):27-32
references.pmid: 11755458
references.citation: J Alzheimers Dis. 2011;24(4):669-79
references.pmid: 21297254
references.citation: Neurobiol Dis. 2000 Aug;7(4):321-31
references.pmid: 10964604
references.citation: Neurosci Lett. 2006 Apr 10-17;397(1-2):83-7
references.pmid: 16406316
references.citation: Biochim Biophys Acta. 2010 Aug;1801(8):762-73
references.pmid: 20580938
references.citation: Biochim Biophys Acta. 2010 Aug;1801(8):945-50
references.pmid: 20226877
references.citation: Acta Psychiatr Scand. 2011 Sep;124(3):184-92
references.pmid: 21585343
references.citation: J Lipid Res. 2004 Aug;45(8):1375-97
references.pmid: 15254070
references.citation: Eur Psychiatry. 2009 Apr;24(3):183-90
references.pmid: 19286353
references.citation: J Neurochem. 2012 Oct;123(2):310-6
references.pmid: 22845771
references.citation: Acta Neuropathol. 2014 May;127(5):633-43
references.pmid: 24633805
references.citation: Biochem Pharmacol. 2013 Jul 1;86(1):26-36
references.pmid: 23541982
references.citation: Science. 2012 Jun 1;336(6085):1168-71
references.pmid: 22654059
references.citation: Nat Neurosci. 2003 Apr;6(4):345-51
references.pmid: 12658281
references.citation: Brain. 2015 Aug;138(Pt 8):2383-98
references.pmid: 26141492
references.citation: Neurobiol Aging. 2003 May-Jun;24(3):421-6
references.pmid: 12600718
references.citation: Alzheimers Res Ther. 2012 Jan 16;4(1):3
references.pmid: 22264400
references.citation: J Neural Transm (Vienna). 2006 Feb;113(2):231-8
references.pmid: 15959845
references.citation: J Alzheimers Dis. 2014;39(4):841-8
references.pmid: 24284365
references.citation: PLoS One. 2010 May 20;5(5):e10659
references.pmid: 20502642
references.citation: Neurosci Lett. 2002 May 10;324(1):83-5
references.pmid: 11983301
references.citation: J Alzheimers Dis. 2013;36(4):739-47
references.pmid: 23666171
references.citation: Dement Geriatr Cogn Disord. 2009;28(1):75-80
references.pmid: 19648749
references.citation: Am J Geriatr Psychiatry. 2008 May;16(5):343-54
references.pmid: 18448847
references.citation: Acta Neurol Scand Suppl. 2006;185:63-70
references.pmid: 16866913
references.citation: Arch Neurol. 2000 Oct;57(10):1439-43
references.pmid: 11030795
references.citation: Neurosci Lett. 2007 Sep 25;425(2):78-82
references.pmid: 17822846
references.citation: Lancet Neurol. 2006 Sep;5(9):735-41
references.pmid: 16914401
references.citation: Alzheimers Dement. 2015 Nov;11(11):1306-15
references.pmid: 25804998
references.citation: J Alzheimers Dis. 2013;33(4):891-911
references.pmid: 23076077
references.citation: Brain Res. 2008 Sep 26;1232:1-6
references.pmid: 18680734
references.citation: Biochem Pharmacol. 2013 Jul 1;86(1):37-42
references.pmid: 23291240
references.citation: Clin Chem Lab Med. 2004 Feb;42(2):186-91
references.pmid: 15061359
references.citation: Neurology. 2002 Jul 23;59(2):198-205
references.pmid: 12136057
references.citation: PLoS One. 2013 Nov 22;8(11):e81482
references.pmid: 24278445
references.citation: Exp Neurol. 2010 Jun;223(2):282-93
references.pmid: 19782682
references.citation: Scand J Clin Lab Invest. 2009;69(1):22-5
references.pmid: 19199127
references.citation: J Alzheimers Dis. 2009;18(2):413-7
references.pmid: 19661632
references.citation: Mol Psychiatry. 2003 Jun;8(6):635-8
references.pmid: 12851640
references.citation: Neurology. 2003 Jul 22;61(2):199-205
references.pmid: 12874399
references.citation: Bioessays. 2003 Jan;25(1):72-8
references.pmid: 12508285
references.citation: Acta Neurol Scand Suppl. 2006;185:43-9
references.pmid: 16866910
references.citation: J Cell Mol Med. 2009 Mar;13(3):589-98
references.pmid: 19374686
references.citation: CNS Neurosci Ther. 2015 Aug;21(8):631-41
references.pmid: 26096465